Biotechnology

Future of BioSciences; The

Four Scenarios for 2020 and Their Implications for Human Healthcare

Publication Date	June 2006
Publisher	Decision Strategies International
Product Type	Book
Pages	132
ISBN Number	not applicable
Product Code	DSI00001

Price

£990.00
approximately: $1,499 | €1,105

pdf

print £1,025 ($1,552 | €1,144)

Order above formats by FAX

In the coming years, the convergence of genomics, proteomics, stem cell research, regenerative medicine, bioinformatics, nanotechnology and other life science technologies will pose significant opportunities and challenges in every sector of society. Two years ago, the William and Phyllis Mack Center for Technological Innovation, part of the Wharton School of the University of Pennsylvania, and Decision Strategies International, Inc. (DSI) embarked on an ambitious program to lay out a range of reasonable futures for biosciences. Based on numerous workshops at the Mack Center and individual interviews with over 50 leading experts from academia, government and the private sector, the report represents a truly unique undertaking. This report presents four scenarios that describe how emerging life science technologies might impact human healthcare between now and 2020. Major trends and uncertainties are identified, as well as key stakeholder groups expected to play a significant role in shaping the future. Our long-term goal is to provide decision makers in various industries with strategic insights needed to develop, commercialize and deploy emerging life science technologies.

Part I: Introduction

Chapter 1: Assessing The Future Of Biosciences

Defining the Biosciences Space
The Scenario Planning Approach

Chapter 2: Biosciences Today

The Remarkable March of Technology
Nanotechnology and Bioinformatics
Industry and Technology Convergence
The Current Pharma Business Model
Developed vs. Developing Markets
Promises and Pitfalls